BeStock  
Stocks › Biotechnology › CRVS

Corvus Pharmaceuticals CRVS

US equityMarket cap rank #3332Biotechnology
$10.41 −$0.15 (-1.42%)
Pre-market · Oct 8, 8:30 am ET · After hours $10.52 +1.06%
Open$10.25
Prev close$10.56
Day range$10.25 – $10.65
Volume1.16M
Market cap$875.70M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$29.50+183.4% vs. price
  • Buy 100%
Low $27.00Now $10.41Avg $29.50High $33.00

Recent rating changes

The last 20 actions on file set price targets from $27.00 to $40.00, averaging $30.80.

DateFirmRatingTarget
11 Aug 2026 Mizuho Securities BUY $30.00
10 Aug 2026 H.C. Wainwright BUY $27.00
7 Aug 2026 Barclays BUY $28.00
7 Aug 2026 Oppenheimer BUY $33.00
1 Jul 2026 H.C. Wainwright BUY $27.00
12 Jun 2026 Mizuho Securities BUY $30.00
18 May 2026 Mizuho Securities BUY $30.00
15 May 2026 H.C. Wainwright BUY $27.00
15 May 2026 Barclays BUY $28.00
14 May 2026 Goldman Sachs BUY $40.00
11 May 2026 Mizuho Securities BUY $30.00
11 May 2026 Goldman Sachs BUY $40.00
8 May 2026 Barclays BUY $28.00
17 Apr 2026 Goldman Sachs BUY $40.00
16 Mar 2026 Mizuho Securities BUY $30.00
16 Mar 2026 Barclays BUY $28.00
13 Mar 2026 H.C. Wainwright BUY $27.00
13 Mar 2026 Oppenheimer BUY $33.00
19 Feb 2026 Mizuho Securities BUY $30.00
29 Jan 2026 Mizuho Securities BUY $30.00

Discussion

No comments yet — be the first to weigh in on CRVS.

Leave a comment

Scroll to Top